Cellectis (CLLS) Treasury Shares (2014 - 2018)
Cellectis (CLLS) recorded quarterly Treasury Shares of $297000.0 in Q3 2018, up 150.6% quarter-over-quarter from -$587000.0 in Q2 2018, and up 160.53% on a YoY basis from $114000.0 in Q3 2017.
Cellectis (CLLS) Treasury Shares (2014 - 2018) Analysis & Trends
Cellectis' Treasury Shares history runs 5 years deep, the most recent figure standing at $297000.0 for Q3 2018.
- In Q3 2018, Treasury Shares rose 160.53% year-over-year to $297000.0; the TTM figure through Sep 2018 stood at $297000.0 (up 160.53% YoY), while the FY2017 annual figure was -$297000.0, down 171.39% from the prior year.
- Treasury Shares was $297000.0 for Q3 2018 at Cellectis, up from -$587000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $331475.3 in Q4 2016 to a low of -$587000.0 in Q2 2018.
- Historically, Treasury Shares has averaged $22134.4 across 5 years, with a median of $80582.5 in 2015.
- The sharpest annual moves came in 2017 and 2018: Treasury Shares surged 2487.4% in 2017, then slumped 601.71% in 2018.
- A 5-year view of Treasury Shares shows it stood at $313708.2 in 2014, then sank by 35.71% to $201685.6 in 2015, then surged by 64.35% to $331475.3 in 2016, then tumbled by 189.6% to -$297000.0 in 2017, then soared by 200.0% to $297000.0 in 2018.
- The last three Treasury Shares figures came in at $297000.0 (Q3 2018), -$587000.0 (Q2 2018), and -$76000.0 (Q1 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 297,000.00 |
| Sep 30, 2018 | 297,000.00 |
| Jun 30, 2018 | -587,000.00 |
| Jun 30, 2018 | -587,000.00 |
| Mar 31, 2018 | -76,000.00 |
| Mar 31, 2018 | -76,000.00 |
| Dec 31, 2017 | -297,000.00 |
| Dec 31, 2017 | -297,000.00 |
| Sep 30, 2017 | 114,000.00 |
| Sep 30, 2017 | 114,000.00 |
| Jun 30, 2017 | 117,000.00 |
| Jun 30, 2017 | 117,000.00 |
| Mar 31, 2017 | 158,000.00 |
| Mar 31, 2017 | 158,000.00 |
| Dec 31, 2016 | 331,475.34 |
| Dec 31, 2016 | 331,475.34 |
| Sep 30, 2016 | -211,000.00 |
| Sep 30, 2016 | -211,000.00 |
| Jun 30, 2016 | -63,273.00 |
| Jun 30, 2016 | -63,273.00 |